Complete Filing Data
TAO Synergies Inc. reported Stockholders Equity of $21.05 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TAO Synergies Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$28.7M | -$12.8M | -$6.0M | -$5.6M | -$12.6M | -$12.7M | -$15.1M |
| Research And Development Expense | $322.2K | $1.6M | $2.0M | $6.3M | $4.3M | $3.1M | $5.7M |
| Operating Expenses | $9.3M | $6.8M | $8.3M | $16.1M | $12.6M | $11.2M | $15.5M |
| General And Administrative Expense | $9.0M | $5.2M | $6.3M | $9.8M | $8.3M | $8.1M | $9.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$28.7M | -$12.8M | -$6.0M | -$5.6M | -$12.6M | -$12.7M | |
| Net Income Loss Available To Common Stockholders Basic | -$29.1M | -$13.6M | -$13.8M | -$5.7M | -$12.6M | -$15.1M | -$15.1M |
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $22.3M | $7.9M | $865.3K | -$5.6M | $3.9M | $4.6M | $3.2M |
| Nonoperating Income Expense | -$19.7M | -$6.0M | $2.3M | $10.6M | $7.1K | -$1.5M | |
| Comprehensive Income Net Of Tax | -$29.1M | -$13.6M | -$13.8M | -$5.7M | |||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | ||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $4.8K | -$902.00 | |||||
| Income Loss From Equity Method Investments | -$44.5K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$12.7M | -$15.1M | |||||
| Revenue From Contract With Customer Excluding Assessed Tax | $299.1K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.9M | -$17.5M | $385.2K | -$5.7M | -$1.3M | -$206.7K | $763.2K | -$4.1M | -$1.7M | -$3.0M | -$3.8M | -$3.3M | -$2.9M | -$2.3M | -$3.2M | -$4.3M | -$4.3M | -$2.5M | -$3.8M |
| Research And Development Expense | $54.4K | $148.6K | $60.8K | $222.9K | $342.1K | $609.2K | $212.1K | $307.2K | $877.7K | $1.5M | $1.9M | $1.5M | $836.7K | $986.3K | $1.2M | $410.3K | $563.3K | $393.2K | $845.8K |
| Operating Expenses | $2.0M | $3.0M | $1.1M | $2.0M | $1.6M | $1.7M | $1.4M | $1.8M | $2.9M | $3.2M | $3.8M | $3.3M | $2.9M | $2.3M | $3.2M | $2.6M | $2.6M | $2.6M | $3.9M |
| General And Administrative Expense | $1.9M | $2.2M | $1.0M | $1.1M | $1.2M | $1.1M | $1.2M | $1.5M | $2.0M | $1.7M | $1.9M | $1.8M | $2.1M | $1.3M | $2.0M | $1.8M | $2.0M | $2.2M | $2.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.9M | -$17.5M | $385.2K | -$5.7M | -$1.3M | -$206.7K | $763.2K | -$4.1M | -$1.7M | -$3.0M | -$3.8M | -$3.3M | -$2.9M | -$2.3M | -$3.2M | -$4.3M | |||
| Net Income Loss Available To Common Stockholders Basic | -$4.0M | -$17.6M | $167.8K | -$6.0M | -$1.4M | -$425.2K | -$361.4K | -$10.2M | -$2.0M | -$3.0M | -$3.8M | -$3.3M | -$2.9M | -$2.3M | -$3.2M | ||||
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | -$2.4M | -$1.6M | $16.0K | -$207.5K | -$432.3K | $798.7K | |||||||||||||
| Nonoperating Income Expense | -$2.1M | -$14.5M | $1.5M | -$3.8M | $307.7K | $1.5M | $2.2M | -$2.3M | $1.2M | $140.7K | $44.5K | $4.6K | $816.00 | ||||||
| Comprehensive Income Net Of Tax | -$4.0M | -$17.6M | $167.8K | -$6.0M | -$1.4M | -$425.9K | -$361.4K | -$10.2M | -$2.0M | ||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $5.4K | $100.00 | -$700.00 | ||||||||||||||||
| Income Loss From Equity Method Investments | -$12.0K | -$9.9K | -$8.6K | ||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$2.3M | -$3.2M | -$4.3M | -$2.9M | -$2.5M | -$3.8M | |||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $203.4K | $4.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $21.1M | $5.9M | $24.3M | $32.7M | $33.5M | $26.7M | $17.4M | $26.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.5M | $17.7M | $28.7M | $37.5M | $34.2M | $5.8M | $17.4M | $28.9M |
| Property Plant And Equipment Net | $9.3K | $12.9K | $18.5K | $22.1K | $20.4K | $22.2K | $21.7K | |
| Prepaid Expense And Other Assets Current | $2.0M | $64.6K | $57.7K | $739.5K | $879.9K | $151.9K | $494.1K | |
| Liabilities Current | $1.8M | $1.0M | $4.3M | $1.3M | $2.0M | $1.6M | $479.1K | |
| Liabilities And Stockholders Equity | $25.8M | $17.7M | $31.1M | $38.6M | $35.5M | $6.8M | $17.9M | |
| Common Stock Value | $746.00 | $137.00 | $96.00 | $728.00 | $674.00 | $126.00 | $17.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$12.2M | -$11.0M | -$8.8M | $3.3M | $28.4M | -$11.6M | -$11.5M | |
| Assets Current | $25.4M | $17.7M | $30.5M | $38.6M | $35.5M | $6.7M | $17.9M | |
| Assets | $25.8M | $17.7M | $31.1M | $38.6M | $35.5M | $6.8M | $17.9M | |
| Accrued Liabilities Current | $638.5K | $697.0K | $435.9K | $536.7K | $698.4K | $352.2K | $66.0K | |
| Accounts Payable Current | $1.2M | $317.3K | $444.6K | $660.2K | $1.3M | $1.3M | $413.1K | |
| Cash And Cash Equivalents At Carrying Value | $5.5M | $17.7M | $28.7M | $37.5M | $34.2M | $5.8M | $17.4M | |
| Retained Earnings Accumulated Deficit | -$76.2M | -$47.2M | -$33.6M | -$19.8M | -$14.1M | -$1.5M | ||
| Temporary Equity Dividends Adjustment | $338.4K | $789.9K | $2.0M | $115.9K | ||||
| Liabilities | $3.9M | $11.0M | $5.5M | $3.2M | $2.0M | |||
| Derivative Liabilities Noncurrent | $2.1M | $6.2M | $1.1M | $370.3K | ||||
| Fair Value Of Derivative Liability | $5.6M | $1.0M | -$743.6K | $1.8M | ||||
| Adjustment To Additional Paid In Capital Temporary Equity Extinguishment Of Deemed Dividend | -$107.0K | -$323.5K | -$210.2K | |||||
| Dividends Preferred Stock | $466.4K | $1.0M | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $2.7M | $33.5M | $5.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.7K | $5.7K | $902.00 | |||||
| Temporary Equity Redemption Value | -$1.4M | -$5.2M | ||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $7.4M | |||||||
| Temporary Equity Accretion Of Dividends | $183.4K | $3.4M | $115.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $16.1M | $17.2M | $5.2M | $12.8M | $18.8M | $22.1M | $26.7M | $24.8M | $31.5M | $26.7M | $29.0M | $31.7M | $31.4M | $32.2M | $15.4M | $5.1M | $29.8M | $32.2M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.4M | $14.4M | $14.8M | $19.6M | $25.0M | $26.3M | $31.7M | $32.9M | $35.8M | $26.3M | $28.8M | $2.9M | $31.3M | $31.7M | $14.8M | $27.0M | $30.3M | $32.2M | $18.9M | |||
| Property Plant And Equipment Net | $10.1K | $10.9K | $11.9K | $14.1K | $15.8K | $17.1K | $19.7K | $21.4K | $22.5K | $21.5K | $20.8K | $19.1K | $18.5K | $19.7K | $21.0K | $23.4K | ||||||
| Prepaid Expense And Other Assets Current | $1.5M | $921.3K | $484.2K | $211.2K | $411.2K | $560.6K | $238.1K | $385.8K | $586.4K | $395.3K | $523.0K | $720.2K | $1.0M | $1.2M | $1.5M | $1.3M | ||||||
| Liabilities Current | $1.0M | $964.3K | $210.7K | $340.9K | $9.4M | $6.3M | $1.8M | $2.8M | $1.3M | $683.6K | $626.0K | $669.3K | $1.0M | $770.0K | $937.4K | $1.3M | ||||||
| Liabilities And Stockholders Equity | $18.4M | $19.8M | $15.3M | $22.8M | $28.4M | $29.4M | $32.4M | $33.4M | $36.5M | $27.4M | $29.6M | $32.4M | $32.4M | $33.0M | $16.3M | $29.1M | ||||||
| Common Stock Value | $453.00 | $251.00 | $140.00 | $137.00 | $127.00 | $109.00 | $1.8K | $738.00 | $737.00 | $685.00 | $682.00 | $682.00 | $615.00 | $604.00 | $1.4K | $27.8M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$2.8M | -$2.3M | -$1.7M | -$2.9M | $9.1M | $14.8M | ||||||||||||||||
| Assets Current | $18.3M | $19.8M | $15.3M | $22.3M | $27.8M | $28.8M | $32.3M | $33.4M | $36.5M | $27.3M | $29.6M | $32.3M | $32.3M | $32.9M | $16.3M | $29.1M | ||||||
| Assets | $18.4M | $19.8M | $15.3M | $22.8M | $28.4M | $29.4M | $32.4M | $33.4M | $36.5M | $27.4M | $29.6M | $32.4M | $32.4M | $33.0M | $16.3M | $29.1M | ||||||
| Accrued Liabilities Current | $92.4K | $66.1K | $96.5K | $54.5K | $47.5K | $45.7K | $76.5K | $68.1K | $538.9K | $200.2K | $345.1K | $268.0K | $72.0K | $121.8K | $178.5K | $110.2K | ||||||
| Accounts Payable Current | $949.7K | $898.2K | $114.2K | $286.4K | $475.3K | $238.9K | $214.2K | $439.1K | $355.9K | $483.4K | $280.9K | $401.3K | $935.4K | $648.2K | $759.0K | $1.2M | ||||||
| Cash And Cash Equivalents At Carrying Value | $14.4M | $14.8M | $19.6M | $25.0M | $26.3M | $31.7M | $32.9M | $35.8M | $26.3M | $28.8M | $31.3M | $31.3M | $31.7M | $14.8M | $27.0M | |||||||
| Retained Earnings Accumulated Deficit | -$68.5M | -$64.5M | -$46.9M | -$41.5M | -$35.5M | -$34.0M | -$32.4M | -$32.0M | -$21.8M | -$24.2M | -$21.2M | -$17.4M | -$9.9M | -$7.0M | -$4.7M | |||||||
| Temporary Equity Dividends Adjustment | $45.2K | $102.7K | $101.4K | $306.7K | $155.7K | $218.5K | $1.1M | $423.6K | $266.1K | |||||||||||||
| Liabilities | $1.7M | $1.8M | $8.9M | $9.7M | $9.6M | $6.5M | $3.9M | $6.5M | $2.3M | |||||||||||||
| Derivative Liabilities Noncurrent | $2.0K | $111.0K | $6.3M | $6.1M | $141.0K | $1.7M | $2.6M | $144.5K | ||||||||||||||
| Fair Value Of Derivative Liability | -$79.0K | $972.0K | $225.8K | |||||||||||||||||||
| Adjustment To Additional Paid In Capital Temporary Equity Extinguishment Of Deemed Dividend | -$53.2K | -$53.8K | -$19.4K | -$120.7K | -$131.0K | |||||||||||||||||
| Dividends Preferred Stock | $45.2K | $49.6K | $47.6K | $287.3K | $35.0K | $87.5K | $192.5K | |||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $1.3M | $912.8K | $823.6K | $1.2M | $1.7M | $2.1M | $31.5M | $26.7M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $5.7K | $5.7K | $5.7K | $5.7K | $302.00 | $202.00 | ||||||||||||||||
| Temporary Equity Redemption Value | -$341.7K | -$620.3K | -$468.3K | -$3.9M | ||||||||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $301.3K | $2.5M | $2.5M | $2.5M | $2.5M | |||||||||||||||||
| Temporary Equity Accretion Of Dividends | $2.6M | $266.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$6.4M | -$4.9M | -$5.2M | -$11.2M | -$8.7M | -$8.1M | -$11.9M |
| Increase Decrease In Accrued Liabilities | -$58.5K | $261.1K | -$100.8K | -$161.7K | $346.3K | $286.2K | $7.5K |
| Depreciation Depletion And Amortization | $3.6K | $5.6K | $6.3K | $5.7K | $5.0K | $4.9K | $4.4K |
| Increase Decrease In Accounts Payable | $858.0K | -$127.3K | -$215.6K | -$636.3K | $36.2K | $847.3K | |
| Employee Benefits And Share Based Compensation | $1.4M | $25.4K | $1.0M | $3.7M | $3.3M | $1.7M | $4.2M |
| Net Cash Provided By Used In Financing Activities | $23.1M | -$5.1M | -$1.6M | $14.5M | $37.1M | -$3.5M | $419.8K |
| Net Cash Provided By Used In Investing Activities | -$28.9M | -$1.0M | -$2.0M | -$7.4K | -$3.2K | -$5.4K | -$5.2K |
| Increase Decrease In Prepaid Expense | -$674.4K | -$183.0K | $356.5K | $439.6K | -$109.2K | ||
| Payments To Acquire Property Plant And Equipment | $2.7K | $7.4K | $3.2K | $5.4K | $5.2K | ||
| Proceeds From Warrant Exercises | $10.0M | $553.2K | $13.4M | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $379.8K | -$368.1K | -$674.4K | ||||
| Payments To Dividends Of Temporary Equity | $262.1K | $950.9K | $641.1K | ||||
| Share Based Compensation |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.0M | -$1.8M | -$1.7M | -$3.5M | -$3.6M | -$1.7M | |||
| Increase Decrease In Accrued Liabilities | -$600.5K | -$390.2K | $2.2K | -$430.4K | -$173.7K | $14.7K | |||
| Depreciation Depletion And Amortization | $1.0K | $1.4K | $1.7K | $1.3K | $1.2K | $1.2K | |||
| Increase Decrease In Accounts Payable | -$203.1K | -$205.7K | -$304.3K | -$895.2K | -$501.4K | -$146.3K | |||
| Employee Benefits And Share Based Compensation | $3.7K | $14.4K | $644.8K | $711.6K | $568.2K | $387.9K | $925.2K | ||
| Net Cash Provided By Used In Financing Activities | -$822.4K | $553.2K | $12.6M | $16.5M | |||||
| Net Cash Provided By Used In Investing Activities | -$500.0K | -$2.0K | -$2.6K | ||||||
| Increase Decrease In Prepaid Expense | -$380.9K | -$237.8K | $670.9K | -$155.3K | |||||
| Payments To Acquire Property Plant And Equipment | $2.0K | $2.6K | |||||||
| Proceeds From Warrant Exercises | $553.2K | $800.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $419.5K | $127.8K | -$380.9K | ||||||
| Payments To Dividends Of Temporary Equity | $107.4K | ||||||||
| Share Based Compensation | $387.9K | $877.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$8.81 | -$10.99 | $29.56 | -$0.81 | $2.51 | $12.03 | $3.01 |
| Weighted Average Number Of Shares Outstanding Basic | 3.3M | 1.2M | 466.1K | 7.0M | 5.0M | 1.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 3.3M | 1.2M | 466.1K | 7.0M | 5.0M | 1.3M | |
| Earnings Per Share Basic | $-8.81 | $-10.99 | $29.56 | $-0.81 | $2.51 | $12.03 | |
| Common Stock Shares Issued | 7.4M | 1.4M | 963.5K | 7.3M | 6.7M | 1.3M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 7.4M | 1.4M | 963.5K | 7.3M | 6.7M | 1.3M | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |
| Temporary Equity Shares Outstanding | 15.0K | ||||||
| Temporary Equity Shares Issued | 15.0K | 0.00 | |||||
| Temporary Equity Shares Authorized | 1.0M | 1.0M | |||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | |||||
| Temporary Equity Face Value Per Share | $1,000.00 | $1,000.00 | |||||
| Preferred Stock Shares Outstanding | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.0M | 5.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.56 | -$11.26 | $0.04 | -$5.01 | -$1.18 | -$0.41 | $0.84 | $1.39 | -$6.59 | $0.43 | $0.54 | $0.47 | $0.47 | $0.58 | $1.06 | -$0.90 | $0.90 | $0.50 | -$1.48 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 2.5M | 1.6M | 1.4M | 1.2M | 1.2M | 1.0M | 428.2K | 294.5K | 300.1K | 7.0M | 7.0M | 6.9M | 6.2M | 4.0M | 3.0M | 4.8M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 2.5M | 1.6M | 1.4M | 1.2M | 1.2M | 1.0M | 428.2K | 294.5K | 300.1K | 7.0M | 7.0M | 6.9M | 6.2M | 4.0M | 3.0M | 4.8M | |||||||
| Earnings Per Share Basic | $-1.56 | $-11.26 | $0.12 | $-5.01 | $-1.18 | $-0.41 | $0.84 | $34.67 | $-6.59 | $0.43 | $0.54 | $0.47 | $0.47 | $0.58 | $1.06 | $0.90 | |||||||
| Common Stock Shares Issued | 4.5M | 2.5M | 1.4M | 1.4M | 1.3M | 1.1M | 17.5M | 7.4M | 7.4M | 6.8M | 6.8M | 6.8M | 6.1M | 6.0M | 14.0M | 1.3M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 4.5M | 2.5M | 1.4M | 1.4M | 1.3M | 1.1M | 17.5M | 7.4M | 7.4M | 6.8M | 6.8M | 6.8M | 6.1M | 6.0M | 14.0M | ||||||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||||||
| Temporary Equity Shares Outstanding | 3.6K | 4.3K | 0.00 | 0.00 | 3.0K | 6.0K | 9.0K | 14.0K | 15.0K | ||||||||||||||
| Temporary Equity Shares Issued | 3.6K | 4.3K | 0.00 | 3.0K | 6.0K | 9.0K | 14.0K | 15.0K | |||||||||||||||
| Temporary Equity Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Temporary Equity Face Value Per Share | $1,000.00 | $1,000.00 | $1,000.00 | ||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 4.0M | 11.9M | 4.8M | 1.3M | 5.0M | 2.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Interest Income Other | $442.9K | $1.3M | $1.6M | $335.0K | $7.1K | $153.2K | $378.7K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.4K | $1.0M | $3.7M | $3.3M | $1.7M | $4.2M | |
| Stock Issued During Period Value Issued For Services | $118.1K | $118.0K | $118.0K | $359.4K | $27.2K | $120.0K | $352.7K |
| Additional Paid In Capital | $97.2M | $53.0M | $58.0M | $52.5M | $47.7M | $6.7M | |
| Derivative Gain Loss On Derivative Net | $5.6M | $1.0M | -$743.6K | $1.8M | |||
| Fair Value Adjustment Of Warrants | $12.4M | $829.0K | -$1.4M | -$8.4M | $1.7M | ||
| Issuance Of Stock And Warrants For Services | $118.1K | $118.0K | $118.0K | $196.6K | $560.0K | $380.7K | $1.1M |
| Adjustments To Additional Paid In Capital Warrant Issued | $2.1M | $196.6K | $560.0K | ||||
| Warrants And Rights Outstanding | $9.0K | $3.8M | $140.0K | $1.5M | |||
| Issuance Of Stock And Warrants For Services Or Claims | $118.0K | $359.4K | $27.2K | $120.0K | $352.7K | ||
| Stock Issued During Period Value Warrants Exercised | $10.0M | $553.2K | $13.4M | ||||
| Prepaid Clinical Trial Expenses | $375.1K | $367.7K | $410.4K | $781.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $43.3K | $152.8K | $182.3K | $300.7K | $330.5K | $463.4K | $550.0K | $427.2K | $396.4K | $140.7K | $44.5K | $4.6K | $2.4K | $1.3K | $816.00 | $6.8K | $6.8K | $70.9K | $90.2K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.7K | $3.8K | $3.4K | $14.4K | $15.1K | $334.4K | $644.8K | $510.7K | $1.0M | $711.6K | $1.2M | $151.6K | $568.2K | $387.9K | $404.3K | $656.8K | |||
| Stock Issued During Period Value Issued For Services | $4.5K | $4.5K | $104.6K | $4.5K | $4.5K | $104.5K | $4.5K | $4.5K | $104.5K | $154.5K | $4.5K | $95.9K | $4.5K | $18.2K | $12.5M | $120.0K | |||
| Additional Paid In Capital | $84.5M | $81.7M | $52.0M | $54.3M | $54.3M | $56.1M | $59.1M | $56.8M | $53.3M | $50.9M | $50.1M | $49.1M | $41.3M | $39.2M | $20.1M | ||||
| Derivative Gain Loss On Derivative Net | $106.0K | -$103.0K | -$79.0K | -$22.0K | $141.0K | $972.0K | $969.0K | -$2.5M | $225.8K | $0.00 | $0.00 | ||||||||
| Fair Value Adjustment Of Warrants | -$109.1K | $14.5M | -$1.4M | $218.0K | $154.0K | -$58.0K | -$674.0K | $207.0K | -$588.0K | $1.7M | |||||||||
| Issuance Of Stock And Warrants For Services | $104.6K | $104.5K | $104.5K | $71.6K | $344.2K | ||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $1.0M | $724.2K | $75.0K | $71.6K | $84.6K | $52.7K | $344.2K | ||||||||||||
| Warrants And Rights Outstanding | $646.0K | $752.0K | $2.4M | $3.3M | $236.0K | $82.0K | $455.0K | $1.1M | $922.0K | ||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $104.5K | $95.9K | $116.9K | ||||||||||||||||
| Stock Issued During Period Value Warrants Exercised | $1.5M | $484.3K | $553.2K | $800.2K | $7.6M | ||||||||||||||
| Prepaid Clinical Trial Expenses | $375.1K | $130.5K | $139.9K | $599.6K | $280.8K | $332.3K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.